🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Autologous Stem Cell Transplant

Analysis of Graft Function Following Autologous Islet Transplantation NCT03097185n/a1 site📍 Dallas Baylor Research Institute MUC1-Activated T Cells for the Treatment of Relapsed and Resistant Ovarian Cancer NCT06483048Phase 11 site📍 Scottsdale Mayo Clinic · Tests: Autologous MUC1-activated T-cells, Bendamustine, Biospecimen Collection, Computed Tomography, Cyclophosphamide Ovarian Tissue Transplantation NCT01870752NA1 site📍 Philadelphia Abramson Cancer Center at Penn Medicine · Tests: Transplantation of previously cryopreserved ovarian tissu A Phase I Interventional Open-label, Non-randomized Dose-escalation Trial to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Immunogenicity, and Preliminary Anti-tumor Activity of Autologous p95HER2.CAR-TECH2Me T Cells in Patients With Selected Advanced Cancers. NCT07593820Phase 12 sites📍 Barcelona📍 Barcelona Vall d'Hebron Institute of Oncology · Tests: p95HER2.CAR-TECH2Me Autologous Dendritic Cell Vaccine in Kidney Cancer NCT05127824Phase 21 site📍 Pittsburgh Jodi Maranchie · Tests: Autologous alpha-DC1/TBVA vaccine, Cabozantinib Master Protocol of TCR-modified T Cell Therapy Targeting HLA-restricted KRAS Antigen Administered in Adult Patients With Metastatic or Locally Advanced PDAC NCT07145450Phase 1, Phase 210 sites📍 Copenhagen📍 Berlin📍 Dresden Anocca AB · Tests: ANOC-001 (TCR-T cells targeting KRAS G12V mutation presented by specific HLA alleles), ANOC-002 (TCR-T cells targeting … Autologous Platelet-rich Plasma in the Treatment of Persistent Epithelial Defects NCT03653650NA1 site📍 Monterrey Universidad Autonoma de Nuevo Leon · Tests: PRP plus BCL, BCL plus PFL, Eye patch plus ocular lubricant ointment Comparison of 40% Glucose Solution and Autologous Blood Patch Pleurodesis for Postoperative Air Leak After Lung Resections NCT06936969NA1 site📍 Poznan Wielkopolskie Centrum Pulmonologii i Torakochirurgii · Tests: Autologous blood patch pleurodesis, 40% glucose solution pleurodesis Autologous Tumor-Infiltrating Lymphocyte (GT307) for Treatment of Patients With Solid Tumours NCT06453057NA1 site📍 Shanghai Grit Biotechnology · Tests: GT307 injection SynKIR-310 for Relapsed/Refractory B-NHL NCT06544265Phase 15 sites📍 Denver📍 Atlanta📍 Fairway Verismo Therapeutics · Tests: SynKIR-310 Autologous Fat Grafting for the Treatment of Chronic Tendinopathy NCT07748793NA1 site📍 New York Weill Medical College of Cornell University · Tests: Adipose Stem/Stromal Cells for Enthesis/Tendon Therapy (ASSET) Injection A Phase Ib Study of GC101 in NSCLC NCT06473961Phase 11 site📍 Shanghai Shanghai Juncell Therapeutics · Tests: Autologous Tumor Infiltrating Lymphocytes A Study of GC101 TIL in Advanced Breast Cancer (10hospital) NCT05142475EARLY Phase 11 site📍 Shanghai Shanghai Juncell Therapeutics · Tests: Tumor Infiltrating Lymphocytes (TIL) CART19 Cells Effects in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Non-Hodgkin's Lymphoma NCT05054257Phase 11 site📍 Prague Institute of Hematology and Blood Transfusion, Czech Republ… · Tests: Autologous CAR19 T lymphocytes A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell ( CAR-T) Therapy in Subjects With Non-relapsing and Progressive Forms of Multiple Sclerosis NCT06138132Phase 11 site📍 Palo Alto Stanford University · Tests: KYV-101 anti-CD19 CAR-T cell therapy, Standard lymphodepletion regimen Autologous Ovarian Tissue Transplantation NCT03496636NA1 site📍 Pittsburgh University of Pittsburgh · Tests: Ovarian tissue transplant Safety and Efficacy of Autologous Transplantation of iPSC-RPE in the Treatment of Macular Degeneration NCT05445063Phase 11 site📍 Beijing Beijing Tongren Hospital · Tests: Autologous iPSC-derived RPE Biological Tumor Infiltrating Lymphocytes Therapy With Immunotherapy for Colon and Rectum Cancer NCT06530303Phase 1, Phase 21 site📍 Beijing Essen Biotech · Tests: Tumor Infiltrating Lymphocytes (TIL), Cyclophosphamide, Fludarabine, Interleukin-2, Pembrolizumab Autologous and Donor-derived CD7 CAR-T Therapy in Refractory or Relapsed T-cell Malignancies NCT06316427Phase 1, Phase 24 sites📍 Beijing📍 Shanghai📍 Shanghai Beijing GoBroad Hospital · Tests: Autologous CD7 CAR T-cell, Prior-HSCT donor-derived CD7 CAR T-cell, New donor-derived CD7 CAR T-cell Study of Ultra-Fast CD19 CAR-T Therapy for Refractory SLE NCT07233642Phase 11 site📍 Hangzhou The Children's Hospital of Zhejiang University School of Me… · Tests: CD19 CAR-T cells Autologous Mitochondrial Transplant for Cerebral Ischemia NCT04998357NA1 site📍 Seattle University of Washington · Tests: Endovascular autologous mitochondrial transplantation ASCT With TEAM Conditioning for Lymphoma With High Risk of CNS Relapse NCT07481669Phase 21 site📍 Hangzhou Second Affiliated Hospital, Zhejiang University, School of … · Tests: TEAM regimen (thiotepa, etoposide, cytarabine and melphalan) AMIC Compared With Microfracture for Focal Articular Cartilage Damage of the Hip NCT05402072Phase 11 site📍 Hamilton McMaster University · Tests: Autologous matrix-induced chondrogenesis (AMIC) CAR-T Cells Therapy for Patients With Autoimmune Diseases NCT07052565NA1 site📍 Hefei Anhui Provincial Hospital · Tests: Anti-BCMA and CD19 CART cells will be injected intravenously on a one-time basis Phase IIa Trial of Anti-CD19 CAR T-Cells in Systemic Sclerosis Resistant to Immunosuppressive Therapy NCT07493395Phase 24 sites📍 Lille📍 Montpellier📍 Paris University Hospital, Montpellier · Tests: CD19 CAR T Arm hSTAR GBM (Hematopoetic Stem Cell (HPC) Rescue for GBM) NCT05052957Phase 21 site📍 Cleveland Leland Metheny · Tests: P140K-MGMT, O6-benzylguanine, Photon Based Radiotherapy, temozolomide, Filgrastim Modified Immune Cells (Autologous Dendritic Cells) and a Vaccine (Prevnar) Combined With Immune Checkpoint Inhibition After High-Dose External Beam Radiation Therapy in Treating Patients With Unresectable Liver Cancer NCT03942328Phase 1, Phase 21 site📍 Rochester Mayo Clinic · Tests: Atezolizumab, Bevacizumab, External Beam Radiation Therapy, Pheresis, Pneumococcal 13-valent Conjugate Vaccine Feasibility and Safety of Collecting and Combining Autologous Hematopoietic Stem Cells With Chimeric Antigen Receptor (CAR) T-Cell Therapy in Subjects With Relapsed/Refractory Hematological Malignancies NCT05887167Phase 11 site📍 Los Angeles Joshua Sasine, MD, PhD · Tests: autologous hematopoietic stem cells added to planned CAR T A Long-term Follow-up Study in Patients Who Received BEAM-101 NCT07373639n/a17 sites📍 Birmingham📍 Phoenix📍 Jacksonville Beam Therapeutics Inc. · Tests: Long-Term Follow-up Study of patients who received BEAM-101 Synthetic Versus Autologous Sling For Stress Incontinence NCT07276295NA7 sites📍 Kelowna📍 Vancouver📍 Vancouver University of British Columbia · Tests: autologous fascia sling, tension-free vaginal tape
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy